Tempest Therapeutics (TPST) Institutional Ownership $6.23 -0.06 (-0.95%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$6.18 -0.05 (-0.80%) As of 05/23/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tempest Therapeutics (NASDAQ:TPST)CurrentInstitutional OwnershipPercentage22.52%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$53.49MNumber ofInstitutional Sellers(last 12 months)0 Get TPST Insider Trade Alerts Want to know when executives and insiders are buying or selling Tempest Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TPST Institutional Buying and Selling by Quarter Tempest Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Millennium Management LLC189,506$158K0.0%N/A0.434% 2/14/2025 Jane Street Group LLC493,094$411K0.0%N/A1.130% 2/14/2025 Northern Trust Corp67,815$57K0.0%+233.2%0.155% 2/13/2025 XTX Topco Ltd160,807$134K0.0%+570.3%0.368% 2/12/2025 Geode Capital Management LLC354,276$296K0.0%+61.0%0.812% 2/12/2025 Versant Venture Management LLC3,507,055$2.93M3.4%N/A8.036% 2/11/2025 Virtu Financial LLC43,105$36K0.0%N/A0.099% 11/16/2024 Geode Capital Management LLC220,067$308K0.0%+42.7%0.873% 11/15/2024 XTX Topco Ltd23,989$34K0.0%N/A0.095% 11/5/2024 Empower Advisory Group LLC35,000$49K0.0%N/A0.139% Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/29/2024 Fullcircle Wealth LLC62,000$87K0.0%N/A0.279% 8/9/2024 Dimensional Fund Advisors LP25,084$55K0.0%N/A0.113% 5/20/2024 Virtu Financial LLC28,574$112K0.0%+69.2%0.129% 2/15/2024 MayTech Global Investments LLC10,000$44K0.0%N/A0.052% 8/14/2023 Rock Springs Capital Management LP536,214$681K0.0%-34.9%4.026% 8/11/2023 Sectoral Asset Management Inc.219,394$279K0.0%N/A1.893% 2/14/2022 Maven Securities LTD77,377$409K0.0%-39.0%1.120% 11/15/2021 Franklin Resources Inc.15,240$221K0.0%N/A0.227% 11/12/2021 Renaissance Technologies LLC34,104$493K0.0%+26.9%0.509% 11/9/2021BlackRock Inc.82,698$1.20M0.0%+1,581.2%1.234% 11/9/2021 Monashee Investment Management LLC60,000$868K0.2%-47.2%0.896% 8/18/2021 Ikarian Capital LLC89,865$1.01M0.1%N/A7.076% 8/17/2021 Boothbay Fund Management LLC10,477$117K0.0%N/A0.825% 8/16/2021 Maven Securities LTD106,628$1.20M0.0%N/A8.396% 8/13/2021 Renaissance Technologies LLC26,867$300K0.0%N/A2.116% 8/13/2021Knott David M13,833$155K0.1%N/A1.089% 8/13/2021 Vanguard Group Inc.61,150$683K0.0%N/A4.815% 8/13/2021 FMR LLC647,898$7.24M0.0%N/A51.016% 8/12/2021 Monashee Investment Management LLC113,644$1.27M0.2%N/A8.948% 5/19/2021 Squarepoint Ops LLC84,879$102K0.0%N/A0.446% 5/17/2021 Ikarian Capital LLC1,348,021$1.62M0.1%+897.1%7.079% 5/17/2021 Goldman Sachs Group Inc.20,883$25K0.0%-50.9%0.110% 5/14/2021 Dimensional Fund Advisors LP51,219$61K0.0%+259.3%0.269% 5/14/2021 Monashee Investment Management LLC500,000$600K0.1%N/A2.626% 5/13/2021 Barclays PLC42,638$51K0.0%-90.8%0.224% 5/13/2021 Renaissance Technologies LLC924,801$1.11M0.0%+66.0%4.856% 5/13/2021Knott David M137,900$165K0.1%N/A0.724% 5/11/2021 Acadian Asset Management LLC291,230$350K0.0%+189.9%1.529% 5/7/2021BlackRock Inc.139,319$167K0.0%+9.8%0.732% (Data available from 1/1/2016 forward) TPST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TPST shares? During the previous two years, 13 institutional investors and hedge funds held shares of Tempest Therapeutics. The most heavily invested institutionals were Versant Venture Management LLC ($2.93M), Rock Springs Capital Management LP ($681K), Jane Street Group LLC ($411K), Geode Capital Management LLC ($296K), Sectoral Asset Management Inc. ($279K), Millennium Management LLC ($158K), and XTX Topco Ltd ($134K).Learn more on TPST's institutional investors. What percentage of Tempest Therapeutics stock is owned by institutional investors? 22.52% of Tempest Therapeutics stock is owned by institutional investors. Learn more on TPST's institutional investor holdings. Which institutional investors have been buying Tempest Therapeutics stock? Of the 12 institutional investors that purchased Tempest Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Versant Venture Management LLC ($3.51M), Jane Street Group LLC ($493.09K), Sectoral Asset Management Inc. ($219.39K), Geode Capital Management LLC ($200.04K), Millennium Management LLC ($189.51K), XTX Topco Ltd ($160.81K), and Fullcircle Wealth LLC ($62K). How much institutional buying is happening at Tempest Therapeutics? Institutional investors have bought a total of 5,004,230 shares in the last 24 months. This purchase volume represents approximately $58.28M in transactions. Which Tempest Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Tempest Therapeutics stock in the last 24 months: Rock Springs Capital Management LP ($287.44K). How much institutional selling is happening at Tempest Therapeutics? Institutional investors have sold a total of 287,440 shares in the last 24 months. This volume of shares sold represents approximately $4.75M in transactions. Related Companies HLVX Major Shareholders CRBU Major Shareholders CABA Major Shareholders CRBP Major Shareholders IZTC Major Shareholders XBIT Major Shareholders ENTX Major Shareholders IVVD Major Shareholders CHRS Major Shareholders CRDL Major Shareholders This page (NASDAQ:TPST) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
